home / stock / celu / celu news


CELU News and Press, Celularity Inc. From 10/30/25

Stock Information

Company Name: Celularity Inc.
Stock Symbol: CELU
Market: NASDAQ
Website: celularity.com

Menu

CELU CELU Quote CELU Short CELU News CELU Articles CELU Message Board
Get CELU Alerts

News, Short Squeeze, Breakout and More Instantly...

CELU - Celularity and DefEYE, Inc. Partner to Advance Growth of Regenerative Therapies in Eye Care

FLORHAM PARK, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company addressing age-related and degenerative diseases, announced today a strategic partnership with DefEYE, Inc. (“DefEYE”), a n...

CELU - Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (PDA-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease

First-in-class regenerative therapy for diabetic foot ulcers complicated by peripheral artery disease Celularity PDA-002 achieved durable wound healing with just two intramuscular doses As a qualified stem cell therapy under Florida statute (§ 458.3245), effective J...

CELU - Celularity Announces Filing of Form 10-Q Quarterly Reports for the First Quarter and the Second Quarter 2025, Confirmation of Nasdaq Listing Rule 5250(c)(1) Compliance

Company on Friday, August 29, 2025, filed quarterly reports on Form 10-Q for the periods ended March 31, 2025, and June 30, 2025, respectively, in accord with its August 11, 2025 updated Nasdaq compliance plan. Company also announces notification by Nasdaq dated September 2, 2025, that it now...

CELU - US Companies Moving the Markets, Evening edition
Tue, Sep 02, 2025 as of 4:00 pm ET

A look at the top 10 most actives in the United States Opendoor Technologies Inc (OPEN) rose 14.4% to $5.09 on volume of 404,498,958 shares Carisma Therapeutics Inc. (CARM) rose 104.7% to $0.44 on volume of 369,969,532 shares HWH International Inc. (HWH) rose 227.8% to $4.72 on volume of 31...

CELU - US Companies Moving the Markets, Morning edition
Tue, Sep 02, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States Carisma Therapeutics Inc. (CARM) rose 125.7% to $0.4853 on volume of 187,473,914 shares Cycurion Inc. (CYCU) rose 12.2% to $0.2246 on volume of 82,960,205 shares Actelis Networks Inc (ASNS) rose 57.6% to $0.5705 on volume of 74,386,133 ...

CELU - US Companies Moving the Markets, Evening edition
Fri, Jul 18, 2025 as of 4:00 pm ET

A look at the top 10 most actives in the United States Opendoor Technologies Inc (OPEN) rose 36.4% to $2.25 on volume of 547,098,005 shares Incannex Healthcare Inc. (IXHL) rose 64.8% to $0.61 on volume of 472,694,351 shares Bit Origin Limited (BTOG) rose 23.6% to $0.78 on volume of 357,677,...

CELU - Celularity & Fountain Life Announce Partnership to Deliver Stem Cell Therapies Under New Florida Law

Fountain Life operates four flagship longevity centers, including two in Florida, where a new state law effective July 1, 2025, authorizes licensed physicians to administer stem cell therapies to members with conditions in orthopedics, wound care, and pain management. FLORHAM PARK, N.J., Ju...

CELU - CELU - Historical Price Movements Surrounding Earnings

2025-07-06 18:46:23 ET Celularity Inc. (CELU) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 6.45%. The average open to low on the day of earnings was -4.97%. The average open to close ...

CELU - CELU - Historical Earnings Price Analysis

2025-07-06 18:41:22 ET Celularity Inc. (CELU) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in CELU stock price following earnings has averaged ±4.16% , with a median of 3.34%. The ...

CELU - Celularity Hails New Florida Law Opening Patient Access to Stem Cell Therapies

New law goes into effect on July 1 st authorizing Florida physicians to provide stem cell therapies to their patients for orthopedics, wound care, and pain management FLORHAM PARK, N.J., July 01, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or th...

Previous 10 Next 10